May 11 (Reuters)-
Kissei Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 69.04 63.23 63.50 31.50
(+9.2 pct) (-12.5 pct) (-8.0 pct) (-2.4 pct)
Operating 1.51 1.86 loss 2.60 loss 1.80
(-19.0 pct) (-70.1 pct)
Recurring 3.48 2.43 loss 1.30 loss 1.10
(+43.1 pct) (-66.1 pct)
Net
Net 5.29 2.82 3.30 3.80
(+87.6 pct) (-48.6 pct) (-37.6 pct) (-13.6 pct)
EPS 113.25 yen 60.31 yen 71.56 yen 82.40 yen
Ann Div 54.00 yen 52.00 yen 56.00 yen
-Q2 Div 27.00 yen 26.00 yen 28.00 yen
-Q4 Div 27.00 yen 26.00 yen 28.00 yen
NOTE - Kissei Pharmaceutical Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T